Lyra Therapeutics, Inc.

Q3 2020 13F Holders

Symbol
LYRA
CUSIP
55234L105
Type
Equity
Class
COM
Num filings
41
Total reported value, excl. options
$85.7 M
Manager Report Date Value ($000) Shares Option Type